{"id":271,"date":"2026-02-28T12:49:47","date_gmt":"2026-02-28T12:49:47","guid":{"rendered":"https:\/\/gastrohospitals.com\/blog\/wilson-disease-definition-uses-and-clinical-overview\/"},"modified":"2026-02-28T12:49:47","modified_gmt":"2026-02-28T12:49:47","slug":"wilson-disease-definition-uses-and-clinical-overview","status":"publish","type":"post","link":"https:\/\/gastrohospitals.com\/blog\/wilson-disease-definition-uses-and-clinical-overview\/","title":{"rendered":"Wilson Disease: Definition, Uses, and Clinical Overview"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\">Wilson Disease Introduction (What it is)<\/h2>\n\n\n\n<p>Wilson Disease is an inherited disorder of copper handling in the body.<br\/>\nIt causes copper to build up over time, especially in the liver and brain.<br\/>\nIn clinical practice, it is most often discussed when evaluating unexplained liver disease or neurologic symptoms.<br\/>\nThe term is commonly used in gastroenterology, hepatology, neurology, and pediatrics.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Why Wilson Disease used (Purpose \/ benefits)<\/h2>\n\n\n\n<p>In day-to-day medicine, \u201cWilson Disease\u201d is used as a diagnostic and management concept rather than a tool or device. Its purpose is to identify a specific, treatable cause of organ injury driven by copper accumulation.<\/p>\n\n\n\n<p>Key clinical reasons it matters include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Explaining liver inflammation and scarring:<\/strong> Wilson Disease can present as hepatitis (liver inflammation), chronic liver disease, cirrhosis (advanced scarring), or acute liver failure. Recognizing it can change the diagnostic workup and overall plan.<\/li>\n<li><strong>Linking liver and extrahepatic findings:<\/strong> Copper can affect the <strong>central nervous system<\/strong> (brain and movement pathways), psychiatric health, eyes (Kayser\u2013Fleischer rings in the cornea), kidneys, and blood cells (hemolysis). The diagnosis provides a unifying explanation when symptoms involve multiple systems.<\/li>\n<li><strong>Guiding targeted therapy and monitoring:<\/strong> When Wilson Disease is confirmed, clinicians can select copper-lowering approaches and define follow-up goals (laboratory trends, symptom changes, and organ function), recognizing that response varies by clinician and case.<\/li>\n<li><strong>Supporting family evaluation:<\/strong> Because it is inherited (autosomal recessive), diagnosis in one person can prompt consideration of assessment in relatives, depending on clinician approach and local practice.<\/li>\n<\/ul>\n\n\n\n<p>Overall, the \u201cbenefit\u201d of using Wilson Disease as a framework is <strong>earlier recognition of a potentially reversible or stabilizable cause of liver and neurologic disease<\/strong>, while acknowledging that outcomes depend on severity at presentation and ongoing follow-up.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Clinical context (When gastroenterologists or GI clinicians use it)<\/h2>\n\n\n\n<p>Gastroenterologists and hepatology clinicians typically consider Wilson Disease in scenarios such as:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Unexplained elevation in liver enzymes (alanine aminotransferase and aspartate aminotransferase) in a child, adolescent, or young adult  <\/li>\n<li>Chronic hepatitis pattern without a clear cause after initial testing (viral, autoimmune, metabolic, medication-related)  <\/li>\n<li>Cirrhosis or portal hypertension of unclear etiology (e.g., low platelets, splenomegaly, varices)  <\/li>\n<li>Acute liver injury or acute liver failure, especially when typical causes are not evident  <\/li>\n<li>Coombs-negative hemolytic anemia (red blood cell breakdown) with concurrent liver abnormalities  <\/li>\n<li>Neuropsychiatric symptoms (tremor, dystonia, parkinsonism, mood or behavioral change) plus abnormal liver tests  <\/li>\n<li>Incidental imaging findings suggesting chronic liver disease in a younger patient  <\/li>\n<li>Evaluation before labeling a patient with \u201ccryptogenic\u201d (unknown-cause) liver disease<\/li>\n<\/ul>\n\n\n\n<p>In gastroenterology practice, Wilson Disease is referenced through <strong>liver-directed testing<\/strong> (blood work, urine copper, imaging) and sometimes <strong>liver biopsy<\/strong> for copper quantification, interpreted alongside clinical features.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Contraindications \/ when it\u2019s NOT ideal<\/h2>\n\n\n\n<p>Wilson Disease itself is a diagnosis, so \u201ccontraindications\u201d usually relate to <strong>when it is less appropriate to prioritize<\/strong> or when <strong>specific diagnostic steps<\/strong> are not ideal in a given context.<\/p>\n\n\n\n<p>Situations where a Wilson-focused pathway may be less suitable or where other approaches may be preferred include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>A clear alternative diagnosis fully explains the presentation<\/strong>, such as confirmed viral hepatitis, advanced alcohol-associated liver disease, or a well-supported autoimmune hepatitis diagnosis (recognizing overlap and diagnostic uncertainty can occur).<\/li>\n<li><strong>Test interpretation is likely to be misleading<\/strong>:<\/li>\n<li>Ceruloplasmin (a copper-binding protein) can be altered by inflammation, pregnancy, estrogen exposure, or severe liver dysfunction, which may complicate interpretation.<\/li>\n<li>Serum copper levels can be confusing because copper is partly carried by ceruloplasmin; values may not reflect total body copper burden in a straightforward way.<\/li>\n<li><strong>Inability to complete or trust a 24-hour urine collection<\/strong>, which can reduce the reliability of urine copper testing (collection errors are common in practice).<\/li>\n<li><strong>Liver biopsy is higher risk or lower yield in some settings<\/strong>, such as significant coagulopathy (impaired clotting) or tense ascites, where the procedural approach and risk-benefit assessment vary by clinician and case.<\/li>\n<li><strong>Hepatic copper quantification may be confounded<\/strong> in some cholestatic (bile flow\u2013impaired) liver diseases that can also raise liver copper content, requiring careful interpretation.<\/li>\n<li><strong>Genetic testing limitations<\/strong>, including variants of uncertain significance and incomplete detection depending on assay design; results often require correlation with clinical findings.<\/li>\n<\/ul>\n\n\n\n<p>When Wilson Disease is not the leading concern, clinicians may focus on broader liver disease evaluation (viral, autoimmune, metabolic, drug-induced, and fatty liver-related causes) while reserving Wilson-specific testing for appropriate cases.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">How it works (Mechanism \/ physiology)<\/h2>\n\n\n\n<p>Wilson Disease results from pathogenic variants in <strong>ATP7B<\/strong>, a gene important for normal copper transport in hepatocytes (liver cells). Under typical physiology:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Copper absorbed from the diet enters the bloodstream and is delivered to the liver.<\/li>\n<li>The liver incorporates copper into <strong>ceruloplasmin<\/strong> and excretes excess copper into bile.<\/li>\n<li>Bile carries copper into the intestine for elimination.<\/li>\n<\/ul>\n\n\n\n<p>In Wilson Disease, impaired ATP7B function leads to two major physiologic consequences:<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>\n<p><strong>Reduced biliary copper excretion<\/strong><br\/>\n   Copper that would normally be excreted into bile is retained in the liver. Over time, hepatic copper accumulation can injure hepatocytes through oxidative stress and other mechanisms, contributing to hepatitis, fibrosis, and cirrhosis.<\/p>\n<\/li>\n<li>\n<p><strong>Disrupted copper incorporation into ceruloplasmin<\/strong><br\/>\n   Ceruloplasmin levels are often low, though not universally. The relationship between ceruloplasmin and copper is clinically relevant because a substantial fraction of circulating copper is protein-bound, so laboratory values require careful interpretation.<\/p>\n<\/li>\n<\/ol>\n\n\n\n<p>As copper burden rises, copper can spill into the bloodstream and deposit in other tissues:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Brain:<\/strong> particularly basal ganglia circuits, contributing to movement disorders and neuropsychiatric symptoms.<\/li>\n<li><strong>Eyes:<\/strong> copper deposition in Descemet membrane can produce Kayser\u2013Fleischer rings, often assessed by slit-lamp examination.<\/li>\n<li><strong>Blood:<\/strong> copper-related oxidative injury may contribute to hemolysis in some cases.<\/li>\n<li><strong>Kidney and other organs:<\/strong> variable involvement.<\/li>\n<\/ul>\n\n\n\n<p><strong>Time course and reversibility:<\/strong> Wilson Disease is typically chronic and progressive without identification and management. Improvement in biochemical abnormalities and some symptoms can occur with copper-lowering strategies, but reversibility varies by clinician and case, symptom duration, and the degree of established organ damage.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Wilson Disease Procedure overview (How it\u2019s applied)<\/h2>\n\n\n\n<p>Wilson Disease is not a single procedure; it is evaluated through a structured clinical workflow that combines history, examination, labs, and targeted diagnostics.<\/p>\n\n\n\n<p>A general, high-level sequence often looks like this:<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>\n<p><strong>History and physical examination<\/strong>\n   &#8211; Liver-related symptoms (fatigue, jaundice, abdominal distension, easy bruising)\n   &#8211; Neuropsychiatric symptoms (tremor, changes in mood or cognition)\n   &#8211; Family history of liver disease or early neurologic disease\n   &#8211; Medication and toxin exposure review to assess competing diagnoses<\/p>\n<\/li>\n<li>\n<p><strong>Initial laboratory evaluation<\/strong>\n   &#8211; Liver biochemistries (aminotransferases, bilirubin, alkaline phosphatase, albumin)\n   &#8211; Coagulation markers (international normalized ratio)\n   &#8211; Complete blood count (for anemia, thrombocytopenia)\n   &#8211; Hemolysis testing when suspected (varies by clinician and case)<\/p>\n<\/li>\n<li>\n<p><strong>Wilson-focused testing<\/strong>\n   &#8211; Ceruloplasmin level\n   &#8211; 24-hour urine copper excretion (requires correct collection technique)\n   &#8211; Serum copper (interpreted cautiously and in context)<\/p>\n<\/li>\n<li>\n<p><strong>Targeted examinations and imaging<\/strong>\n   &#8211; Slit-lamp eye exam for Kayser\u2013Fleischer rings\n   &#8211; Abdominal ultrasound or cross-sectional imaging to assess liver morphology and portal hypertension features\n   &#8211; Brain magnetic resonance imaging (MRI) when neurologic features are prominent (used selectively)<\/p>\n<\/li>\n<li>\n<p><strong>Confirmatory testing when needed<\/strong>\n   &#8211; <strong>Liver biopsy<\/strong> for hepatic copper quantification and histology (pattern can vary)\n   &#8211; <strong>Genetic testing<\/strong> for ATP7B variants, often used alongside biochemical and clinical data rather than as a standalone answer<\/p>\n<\/li>\n<li>\n<p><strong>Interpretation and follow-up<\/strong>\n   &#8211; Clinicians integrate results (often using standardized diagnostic frameworks) to classify likelihood and decide next steps.\n   &#8211; Follow-up typically tracks liver function, copper-related markers, symptoms, and treatment tolerance where applicable.<\/p>\n<\/li>\n<\/ol>\n\n\n\n<p>This overview is intentionally general; exact pathways differ across institutions and patient presentations.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Types \/ variations<\/h2>\n\n\n\n<p>Wilson Disease can vary in presentation, organ involvement, and clinical course. Commonly described variations include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Hepatic-predominant Wilson Disease<\/strong><\/li>\n<li>May resemble acute hepatitis, chronic hepatitis, fatty liver-like changes, or cirrhosis.<\/li>\n<li>\n<p>Portal hypertension complications (ascites, variceal bleeding risk) may occur in advanced disease.<\/p>\n<\/li>\n<li>\n<p><strong>Neurologic-predominant Wilson Disease<\/strong><\/p>\n<\/li>\n<li>Movement disorders (tremor, dystonia, rigidity) and speech\/swallowing difficulties can be prominent.<\/li>\n<li>\n<p>Liver tests may be normal or only mildly abnormal in some cases.<\/p>\n<\/li>\n<li>\n<p><strong>Psychiatric\/behavioral-predominant presentations<\/strong><\/p>\n<\/li>\n<li>\n<p>Mood symptoms, personality change, or cognitive difficulties may lead to initial psychiatric evaluation before liver disease is recognized.<\/p>\n<\/li>\n<li>\n<p><strong>Acute liver failure presentations<\/strong><\/p>\n<\/li>\n<li>Some patients present with rapid deterioration in liver function; hemolysis can accompany this pattern.<\/li>\n<li>\n<p>Diagnostic testing may be challenging because standard markers can shift with severe illness.<\/p>\n<\/li>\n<li>\n<p><strong>Presymptomatic or screen-detected disease<\/strong><\/p>\n<\/li>\n<li>\n<p>Identified during family evaluation or incidental workup for abnormal liver enzymes.<\/p>\n<\/li>\n<li>\n<p><strong>Age-related variation<\/strong><\/p>\n<\/li>\n<li>Often recognized in children\/young adults, but later presentations can occur; clinician suspicion depends on context.<\/li>\n<\/ul>\n\n\n\n<p>Diagnostic \u201cvariations\u201d also include different combinations of tests used (biochemical panels, urine testing, ophthalmologic exam, imaging, biopsy, genetics), chosen based on presentation and local resources.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Pros and cons<\/h2>\n\n\n\n<p>Pros:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Helps identify a <strong>specific, inherited<\/strong> cause of liver disease that may otherwise be labeled \u201ccryptogenic\u201d<\/li>\n<li>Encourages a <strong>system-based<\/strong> evaluation that connects liver, neurologic, psychiatric, ophthalmologic, and hematologic findings<\/li>\n<li>Multiple complementary tests can support diagnosis when one result is indeterminate<\/li>\n<li>Early recognition can support <strong>organ-preserving management<\/strong>, with response varying by clinician and case<\/li>\n<li>Genetic confirmation can clarify diagnosis and support family risk assessment where appropriate<\/li>\n<\/ul>\n\n\n\n<p>Cons:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Presentation can be <strong>nonspecific<\/strong>, mimicking viral hepatitis, autoimmune hepatitis, fatty liver disease, or psychiatric disorders<\/li>\n<li>No single test is perfect; false positives\/negatives can occur, and interpretation is context-dependent<\/li>\n<li>Some confirmatory steps (e.g., liver biopsy) are invasive and may not be feasible in all patients<\/li>\n<li>Monitoring can be long-term and requires coordinated care across specialties in some cases<\/li>\n<li>Access to specialized testing (quantitative hepatic copper, genetics, slit-lamp exam) may vary by region and institution<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Aftercare &amp; longevity<\/h2>\n\n\n\n<p>Because Wilson Disease is chronic, \u201caftercare\u201d generally refers to ongoing monitoring of organ function and treatment effects rather than short-term recovery alone.<\/p>\n\n\n\n<p>Factors that commonly influence longer-term outcomes include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Severity and pattern at diagnosis:<\/strong> Advanced fibrosis\/cirrhosis, portal hypertension, or severe neurologic involvement may be less reversible than early disease.<\/li>\n<li><strong>Consistency of follow-up:<\/strong> Regular reassessment helps clinicians adjust plans based on lab trends, symptoms, and tolerance. Follow-up intervals vary by clinician and case.<\/li>\n<li><strong>Medication tolerance and adherence:<\/strong> Copper-lowering regimens can have side effects or interactions; maintaining a workable plan is often a major determinant of stability.<\/li>\n<li><strong>Nutrition and copper exposure:<\/strong> Dietary counseling is sometimes used as supportive care alongside medical therapy; specific recommendations vary by clinician and case.<\/li>\n<li><strong>Comorbidities:<\/strong> Alcohol use disorder, viral hepatitis, metabolic syndrome, and other liver stressors can worsen overall trajectory.<\/li>\n<li><strong>Monitoring for complications:<\/strong> Patients with cirrhosis may need surveillance strategies typical for chronic liver disease (e.g., portal hypertension management and liver cancer surveillance), tailored to the individual.<\/li>\n<\/ul>\n\n\n\n<p>\u201cLongevity\u201d of benefit from management depends on how early disease is recognized, how well copper burden is controlled, and whether irreversible organ damage is already present.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Alternatives \/ comparisons<\/h2>\n\n\n\n<p>Wilson Disease is a diagnosis with a specific mechanism, so \u201calternatives\u201d usually mean <strong>other conditions in the differential diagnosis<\/strong> or <strong>different approaches to evaluation and management<\/strong>.<\/p>\n\n\n\n<p>Common comparisons in gastroenterology and hepatology include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Wilson Disease vs other metabolic\/genetic liver diseases<\/strong><\/li>\n<li><em>Hereditary hemochromatosis:<\/em> iron overload rather than copper; different labs and organ pattern.<\/li>\n<li><em>Alpha-1 antitrypsin deficiency:<\/em> misfolded protein accumulation; lung involvement can coexist.<\/li>\n<li>\n<p>These disorders can look similar clinically (elevated liver enzymes, cirrhosis) but require different confirmatory tests.<\/p>\n<\/li>\n<li>\n<p><strong>Wilson Disease vs autoimmune hepatitis<\/strong><\/p>\n<\/li>\n<li>Both can present with hepatitis and elevated aminotransferases.<\/li>\n<li>\n<p>Autoimmune hepatitis relies more on autoantibodies, immunoglobulin G patterns, and histology; Wilson Disease relies on copper-related testing and genetics.<\/p>\n<\/li>\n<li>\n<p><strong>Wilson Disease vs nonalcoholic fatty liver disease (NAFLD) \/ metabolic dysfunction\u2013associated steatotic liver disease (MASLD)<\/strong><\/p>\n<\/li>\n<li>\n<p>Fatty liver is common and can coexist with other problems; Wilson Disease is less common but clinically important not to miss in appropriate age groups and contexts.<\/p>\n<\/li>\n<li>\n<p><strong>Observation\/monitoring vs definitive workup<\/strong><\/p>\n<\/li>\n<li>Mild, nonspecific liver test abnormalities are sometimes rechecked before extensive evaluation.<\/li>\n<li>\n<p>In higher-risk contexts (young age, neuropsychiatric findings, signs of liver dysfunction), clinicians may prioritize earlier targeted testing.<\/p>\n<\/li>\n<li>\n<p><strong>Medication vs transplant pathways<\/strong><\/p>\n<\/li>\n<li>Most discussions focus on copper-lowering medication strategies (chelators or zinc-based approaches) and monitoring.<\/li>\n<li>Liver transplantation is considered when liver failure is advanced or rapidly progressive, but selection depends on severity and center-specific criteria.<\/li>\n<\/ul>\n\n\n\n<p>These comparisons emphasize that Wilson Disease evaluation sits within a broader framework of assessing liver injury pattern, time course, and multisystem clues.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Wilson Disease Common questions (FAQ)<\/h2>\n\n\n\n<p><strong>Q: Is Wilson Disease a liver disease or a neurologic disease?<\/strong><br\/>\nIt is both. Copper first accumulates in the liver, but over time it can affect the brain, eyes, blood cells, and other organs. The dominant symptoms vary across patients and across stages of disease.<\/p>\n\n\n\n<p><strong>Q: How do clinicians test for Wilson Disease?<\/strong><br\/>\nTesting typically combines blood tests (including ceruloplasmin), urine copper measurement, and a slit-lamp eye exam for Kayser\u2013Fleischer rings. Imaging may assess liver structure or brain changes, and confirmation sometimes involves liver biopsy or genetic testing. Results are interpreted together because no single test is definitive in every case.<\/p>\n\n\n\n<p><strong>Q: Does testing require fasting or special preparation?<\/strong><br\/>\nSome components do not require fasting, but urine copper testing requires correct 24-hour collection technique. If a liver biopsy or sedated procedure is planned, specific preparation instructions may apply. Preparation varies by clinician and case.<\/p>\n\n\n\n<p><strong>Q: Is a liver biopsy always necessary?<\/strong><br\/>\nNot always. Many patients can be diagnosed with a combination of clinical features, copper-related labs, eye findings, and\/or genetic testing. Biopsy is generally reserved for unclear cases or when clinicians need additional information about liver injury and copper content.<\/p>\n\n\n\n<p><strong>Q: Is Wilson Disease testing painful or does it require anesthesia?<\/strong><br\/>\nBlood tests and urine collection are not typically painful beyond routine phlebotomy. A slit-lamp eye exam is usually noninvasive. Liver biopsy, when performed, is an invasive procedure and may use local anesthesia and sometimes sedation depending on the approach and setting.<\/p>\n\n\n\n<p><strong>Q: How long does it take to get results?<\/strong><br\/>\nTiming depends on the test. Routine blood tests may return quickly, while specialized copper studies and genetic testing can take longer. Turnaround time varies by laboratory and institution.<\/p>\n\n\n\n<p><strong>Q: What are the main treatments used for Wilson Disease?<\/strong><br\/>\nTreatment generally focuses on lowering the body\u2019s copper burden and preventing re-accumulation. Common approaches include copper chelating medications and zinc-based therapy, with the choice depending on presentation and tolerance. Advanced liver failure may require transplant evaluation.<\/p>\n\n\n\n<p><strong>Q: How long do treatment effects last?<\/strong><br\/>\nWilson Disease typically requires long-term management rather than a one-time cure. Biochemical improvement can occur over time, but symptom response and durability vary by clinician and case and by the degree of organ damage at diagnosis. Ongoing monitoring is commonly used to assess control.<\/p>\n\n\n\n<p><strong>Q: Is Wilson Disease considered \u201csafe\u201d to manage long-term?<\/strong><br\/>\nLong-term management is possible for many patients, but safety depends on medication choice, dose, side effects, and monitoring. Some therapies can affect blood counts, kidneys, or other systems, so clinicians often use periodic labs to watch for adverse effects. Individual risk varies by clinician and case.<\/p>\n\n\n\n<p><strong>Q: Can people return to school or work during evaluation or treatment?<\/strong><br\/>\nMany can, especially during outpatient testing and routine follow-up. Limitations may occur if symptoms are significant (fatigue, neurologic impairment) or if hospitalization is needed for severe liver disease. Return-to-activity expectations vary by clinician and case.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Wilson Disease is an inherited disorder of copper handling in the body. It causes copper to build up over time, especially in the liver and brain. In clinical practice, it is most often discussed when evaluating unexplained liver disease or neurologic symptoms. The term is commonly used in gastroenterology, hepatology, neurology, and pediatrics.<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-271","post","type-post","status-publish","format-standard","hentry"],"_links":{"self":[{"href":"https:\/\/gastrohospitals.com\/blog\/wp-json\/wp\/v2\/posts\/271","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/gastrohospitals.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/gastrohospitals.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/gastrohospitals.com\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/gastrohospitals.com\/blog\/wp-json\/wp\/v2\/comments?post=271"}],"version-history":[{"count":0,"href":"https:\/\/gastrohospitals.com\/blog\/wp-json\/wp\/v2\/posts\/271\/revisions"}],"wp:attachment":[{"href":"https:\/\/gastrohospitals.com\/blog\/wp-json\/wp\/v2\/media?parent=271"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/gastrohospitals.com\/blog\/wp-json\/wp\/v2\/categories?post=271"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/gastrohospitals.com\/blog\/wp-json\/wp\/v2\/tags?post=271"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}